Asahi Life Asset Management Co., Ltd. Moderna, Inc. Transaction History

Asahi Life Asset Management Co., Ltd.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 02, 2023	BUY	$96.41 - $126.61 $321,045 - $421,611	3,330 New	3,330 $343,000
Q2 2022 Aug 02, 2022	BUY	$117.13 - $176.59 $343,190 - $517,408	2,930 New	2,930 $419,000
Q4 2021 Feb 02, 2022	SELL	$225.82 - $368.51 $90,328 - $147,404	-400 Closed	0 $0
Q3 2021 Oct 29, 2021	SELL	$221.9 - $484.47 $213,024 - $465,091	-960 Reduced 70.59%	400 $154,000
Q2 2021 Aug 10, 2021	BUY	$129.91 - $234.98 $176,677 - $319,572	1,360 New	1,360 $320,000
Q3 2020 Nov 02, 2020	SELL	$54.34 - $94.85 $182,582 - $318,696	-3,360 Closed	0 $0
Q2 2020 Aug 05, 2020	BUY	$29.67 - $80.0 $99,691 - $268,800	3,360 New	3,360 $216,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Asahi Life Asset Management Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on Asahi Life Asset Management Co., Ltd. with notifications on news.